Research Topics
Species | Rajiv K PruthiSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trialRajiv K Pruthi
Comprehensive Hemophilia Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Thromb Haemost 98:726-32. 2007..Serious adverse events were related to continued or increased bleeding. In conclusion, haemostatic efficacy and safety of BI and CI of rFVIIa are comparable for the surgical management of haemophilia subjects with inhibitors...
Autoimmune factor VIII inhibitorsR K Pruthi
Department of Internal Medicine and Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA
Curr Opin Hematol 6:314-22. 1999..Future laboratory and clinical studies are necessary for advancement of pathophysiologic knowledge and therapeutic options for patients with this uncommon but clinically important disorder...
A practical approach to genetic testing for von Willebrand diseaseRajiv K Pruthi
Department of Internal Medicine and Division of Hematology, Special Coagulation DNA Diagnostic Laboratory, Comprehensive Hemophilia Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Mayo Clin Proc 81:679-91. 2006..This article provides a practical approach to utilization of genetic testing in vWD...
Hemophilia: a practical approach to genetic testingRajiv K Pruthi
Department of Internal Medicine, Division of Hematology, Special Coagulation DNA Diagnostic Laboratory, and Comprehensive Hemophilia Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Mayo Clin Proc 80:1485-99. 2005..This article provides a practical approach to using genetic testing for hemophilia A and B...
Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G)Rajiv K Pruthi
Special Coagulation Laboratory, Mayo Clinic, Rochester, MN 55905, USA
Eur J Haematol 79:354-9. 2007..This mutation in the heterozygous form was also present in a mildly affected, unrelated patient. We also report on the natural history of an FVII inhibitor in the patient with severe FVII deficiency...
Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imagingRajiv K Pruthi
Special Coagulation Laboratory, Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN 55905, USA
Thromb Res 126:543-9. 2010....
Five things oculoplastic surgeons should know about the preoperative assessment of hemostasisRajiv K Pruthi
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Ophthal Plast Reconstr Surg 18:396-401. 2002
Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders: a follow-up survey and systematic reviewSherif A El-Nashar
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA
Am J Obstet Gynecol 202:348.e1-7. 2010..The purpose of this study was to describe health-related quality of life and satisfaction after global endometrial ablation in women with bleeding disorders and a systematic review of the literature...
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapyMichelle A Elliott
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Eur J Haematol 88:237-43. 2012..Therapy-related APL is sensitive to standard therapy with no cases of resistance or relapse seen. The inferior OS of the t-APL was due to induction mortality, possibly reflecting prior therapy...
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic considerationMichelle A Elliott
Division of Hematology Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Eur J Haematol 85:43-50. 2010..Recognition of cancer-associated microangiopathic hemolytic anemia with thrombocytopenia (CA-MHA) is paramount to avoid inappropriate PE therapy and delays in cancer-specific chemotherapy...
Acquired von Willebrand's syndrome: a single institution experienceShaji Kumar
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Hematol 72:243-7. 2003..AVWS may be more prevalent than has been appreciated; we estimate up to 0.04%. Awareness of the existence of AVWS is essential for diagnosis and appropriate management. Therapy of associated diseases may improve the bleeding disorder...
Bacterial endocarditis and septic arthritis in a patient with severe hemophilia A: a case reportRuetima Titapiwatanakun
Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN 55905, USA
J Pediatr Hematol Oncol 31:344-5. 2009..Endocarditis and septic arthritis in patients with hemophilia are rare infectious complications but should be considered in patients with persistent bacteremia...
Hemostatic management of an infant with severe hemophilia A and tetralogy of Fallot for cardiac bypass surgeryVilmarie Rodriguez
Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
Pediatr Blood Cancer 55:1399-401. 2010..Although cardiac surgery is successful, exposure to factor concentrates in severe hemophilia early in life might predispose a patient to inhibitor development...
JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patientsAnimesh Pardanani
Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 83:457-9. 2008..Our study also suggests that the natural history of a JAK2V617F-positive "occult" MPN might be different from that of a typical MPN...
How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adultsArif H Kamal
Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 82:864-73. 2007....
Pelvic pseudotumor and pseudoaneurysm in a pediatric patient with moderate hemophilia B: successful management with arterial embolization and surgical excisionRiten Kumar
Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
Pediatr Blood Cancer 56:484-7. 2011..He was successfully treated with Bead Block and coil embolization followed by surgical extirpation of the lesion 24 hr later...
Transient neonatal acquired von Willebrand syndrome due to transplacental transfer of maternal monoclonal antibodiesAmulya A Nageswara Rao
Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
Pediatr Blood Cancer 53:655-7. 2009....
Acquired von Willebrand diseaseShaji Kumar
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 77:181-7. 2002..Intravenous immunoglobulins have also shown some efficacy in the management of AvWD, especially cases associated with monoclonal gammopathies. Awareness of AvWD is essential for diagnosis and appropriate management...
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemiaGordon W Dewald
Division of Laboratory Genetics, Mayo Clinic, Rochester, MN 55905, USA
Br J Haematol 121:287-95. 2003..Importantly, only CD38+ was significantly associated with high-risk FISH categories (+12, 11q- and 17p-) after adjustment for the effects of other variables...
Central venous access devices for paediatric patients with haemophilia: a single-institution experienceR Titapiwatanakun
Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota, USA
Haemophilia 15:168-74. 2009..The low rate of clinically apparent thrombosis reflects our practice of not screening for thrombosis. The low infection rate reflects our practice of using and reinforcing the aseptic technique...
Intracranial haemorrhage as initial presentation of severe haemophilia B: case report and review of Mayo Clinic Comprehensive Hemophilia Center experienceV Rodriguez
Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN, USA
Haemophilia 11:73-7. 2005..His family history was negative for haemophilia. Review of our institutional experience as well as the literature indicates that intracranial bleeding as the initial presentation of haemophilia is rare...
To circumcise or not to circumcise? Circumcision in patients with bleeding disordersV Rodriguez
Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN 55905, USA
Haemophilia 16:272-6. 2010..Some of our patients had significant bleeding despite adequate factor replacement before and after the procedure. Parents and patients must be aware that bleeding risk is a possibility despite adequate factor replacement for hemostasis...
A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometryD Chen
Special Coagulation Laboratory, Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
J Thromb Haemost 6:323-30. 2008..However, current manual or automated VWF:RCo assay methods have relatively poor operating characteristics. Our goal was to develop and validate a simple, accurate, specific and sensitive platelet-based VWF:RCo assay...
Novel splice site mutations in the gamma glutamyl carboxylase gene in a child with congenital combined deficiency of the vitamin K-dependent coagulation factors (VKCFD)Ruetima Titapiwatanakun
Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
Pediatr Blood Cancer 53:92-5. 2009..Oral vitamin K supplementation resulted in partial resolution of proteins and complete resolution of bleeding...
Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literatureMischelle A Elliott
Department of Internal Medicine Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Eur J Haematol 83:365-72. 2009..Prospective studies are urgently needed to define the true efficacy and long-term safety of rituximab...
Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literatureElizabeth A Jaben
Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA
J Clin Apher 26:219-24. 2011..Following PE and subsequent CPB, neither patient had clinical or laboratory evidence of HIT. The literature regarding the use of PE for the treatment of complications of HIT and as prophylaxis before CPB is reviewed...
Outcomes of management of acute coronary syndrome in patients with congenital bleeding disorders: a single center experience and review of the literatureMing Y Lim
Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Thromb Res 130:316-22. 2012..Evidence-based guidelines for the management of acute coronary syndrome (ACS) in patients with congenital bleeding disorders are lacking and largely confined to case reports...
Cardiovascular disease risk factors: prevalence and management in adult hemophilia patientsMing Y Lim
Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Blood Coagul Fibrinolysis 22:402-6. 2011..Collaborative efforts between primary care providers, cardiologists and hemophilia center specialists remain essential in managing these complex patients...
Haemorrhage into a popliteal cyst: an unusual complication of haemophilia AV Rodriguez
Comprehensive Hemophilia Center, Mayo Clinic, Rochester, Minnesota 55905, USA
Haemophilia 8:725-8. 2002..Imaging studies showed that by day 10 a popliteal cyst had ruptured, with diffusion of blood into the calf muscles. This case illustrates another possible bleeding complication in patients with a bleeding disorder and a popliteal cyst...
Global endometrial ablation for menorrhagia in women with bleeding disordersSherif A El Nashar
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota 55905, USA
Obstet Gynecol 109:1381-7. 2007..To evaluate the efficacy of global endometrial ablation in women with bleeding disorders who presented with menorrhagia...
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombinMichelle A Elliott
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Leuk Lymphoma 45:1545-9. 2004..021). These observations merit further study to gain insight into disease and/or therapy-specific pathogenesis of TE in this population and call for the prospective evaluation of appropriate prophylactic interventions...
Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinosideWilliam J Hogan
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 77:760-2. 2002..CONCLUSION: This analysis suggests that neutropenic colitis is a frequent and serious complication of idarubicin and cytosine arabinoside treatment...
Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemiaVahid Afshar-Kharghan
Thrombosis Research Section, Baylor College of Medicine, Houston, Texas, USA
Blood Coagul Fibrinolysis 15:21-4. 2004..In view of previous studies linking the presence of the PlA2 allele of GPIIIa to a higher risk for coronary artery thrombosis, our data have physiologic relevance. However, they need to be confirmed in a larger study...
